139 related articles for article (PubMed ID: 11254642)
1. Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis.
Madan T; Kishore U; Singh M; Strong P; Hussain EM; Reid KB; Sarma PU
Infect Immun; 2001 Apr; 69(4):2728-31. PubMed ID: 11254642
[TBL] [Abstract][Full Text] [Related]
2. Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens.
Madan T; Kishore U; Singh M; Strong P; Clark H; Hussain EM; Reid KB; Sarma PU
J Clin Invest; 2001 Feb; 107(4):467-75. PubMed ID: 11181646
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of recombinant forms of full-length and truncated human surfactant protein D in a murine model of invasive pulmonary aspergillosis.
Singh M; Madan T; Waters P; Sonar S; Singh SK; Kamran MF; Bernal AL; Sarma PU; Singh VK; Crouch EC; Kishore U
Mol Immunol; 2009 Jul; 46(11-12):2363-9. PubMed ID: 19403176
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis.
Lewis RE; Liao G; Hou J; Chamilos G; Prince RA; Kontoyiannis DP
Antimicrob Agents Chemother; 2007 Apr; 51(4):1253-8. PubMed ID: 17261624
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of mice genetically deficient in SP-A or SP-D gene to invasive pulmonary aspergillosis.
Madan T; Reid KB; Clark H; Singh M; Nayak A; Sarma PU; Hawgood S; Kishore U
Mol Immunol; 2010 Jun; 47(10):1923-30. PubMed ID: 20413160
[TBL] [Abstract][Full Text] [Related]
6. Protective roles of pulmonary surfactant proteins, SP-A and SP-D, against lung allergy and infection caused by Aspergillus fumigatus.
Kishor U; Madan T; Sarma PU; Singh M; Urban BC; Reid KB
Immunobiology; 2002 Sep; 205(4-5):610-8. PubMed ID: 12396019
[TBL] [Abstract][Full Text] [Related]
7. Localization and developmental expression of surfactant proteins D and A in the respiratory tract of the mouse.
Wong CJ; Akiyama J; Allen L; Hawgood S
Pediatr Res; 1996 Jun; 39(6):930-7. PubMed ID: 8725251
[TBL] [Abstract][Full Text] [Related]
8. [An experimental study of the therapeutic effect of interleukin-2 and interleukin-12 with and without amphotericin B on pulmonary fungal infection].
Zhang CR; Tang YC; Kawakami K; Zhang TT; Zhang KX; Zhu JX
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):234-6. PubMed ID: 15144612
[TBL] [Abstract][Full Text] [Related]
9. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.
Atochina EN; Beck JM; Scanlon ST; Preston AM; Beers MF
J Lab Clin Med; 2001 Jun; 137(6):429-39. PubMed ID: 11385364
[TBL] [Abstract][Full Text] [Related]
10. Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis.
Kaur S; Gupta VK; Thiel S; Sarma PU; Madan T
Clin Exp Immunol; 2007 May; 148(2):382-9. PubMed ID: 17335555
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis.
Gavaldà J; Martín T; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Puigfel Y; Ruiz I; Pahissa A
Clin Microbiol Infect; 2005 Dec; 11(12):999-1004. PubMed ID: 16307554
[TBL] [Abstract][Full Text] [Related]
12. In vivo resistance of a laboratory-selected Aspergillus fumigatus isolate to amphotericin B.
Manavathu EK; Cutright JL; Chandrasekar PH
Antimicrob Agents Chemother; 2005 Jan; 49(1):428-30. PubMed ID: 15616327
[TBL] [Abstract][Full Text] [Related]
13. Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis.
Mehrad B; Strieter RM; Standiford TJ
J Immunol; 1999 Feb; 162(3):1633-40. PubMed ID: 9973423
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of nebulized amphotericin B to prevent or treat pulmonary aspergillosis in immunosuppressed animals.
Ho KM; Duff O; Chambers D; Murray R
Transpl Infect Dis; 2008 Jun; 10(3):168-76. PubMed ID: 18194368
[TBL] [Abstract][Full Text] [Related]
15. Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A.
Elhalwagi BM; Zhang M; Ikegami M; Iwamoto HS; Morris RE; Miller ML; Dienger K; McCormack FX
Am J Respir Cell Mol Biol; 1999 Sep; 21(3):380-7. PubMed ID: 10460755
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic administration of liposomal amphotericin B is superior to treatment in a murine model of invasive aspergillosis after hematopoietic cell transplantation.
BitMansour A; Brown JM
J Infect Dis; 2002 Jul; 186(1):134-7. PubMed ID: 12089676
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses.
Cenci E; Mencacci A; Del Sero G; Bacci A; Montagnoli C; d'Ostiani CF; Mosci P; Bachmann M; Bistoni F; Kopf M; Romani L
J Infect Dis; 1999 Dec; 180(6):1957-68. PubMed ID: 10558953
[TBL] [Abstract][Full Text] [Related]
18. A non-immunosuppressed patient with presumably invasive pulmonary aspergillosis and a favourable outcome.
Schrijver G; Verwers HR; Meinders AE
Neth J Med; 1983; 26(4):112-9. PubMed ID: 6343901
[No Abstract] [Full Text] [Related]
19. Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis.
Rieg G; Spellberg B; Schwartz J; Fu Y; Edwards JE; Sheppard DC; Ibrahim AS
Antimicrob Agents Chemother; 2006 Aug; 50(8):2895-6. PubMed ID: 16870798
[No Abstract] [Full Text] [Related]
20. Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome.
Häfner D; Germann PG; Hauschke D
Br J Pharmacol; 1998 Jul; 124(6):1083-90. PubMed ID: 9720777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
